Menu ×

HEALTHCARE & PHARMACEUTICAL

Functional Electrical Stimulation Market Segmentation by Product Type (Wired Devices, Wireless Devices, and Others); by Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, and Others), and by End-User (Hospitals, Clinics, Ambulatory Health Center, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Functional Electrical Stimulation Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • January, 2022: Pfizer Inc., and Beam Therapeutic Inc., to join hands for multi-target research for in-vivo base editing programs for a range of rare diseases.

  • February, 2021: Pfizer Inc. and Imcyse, a clinical-stage biopharmaceutical company, announced a research collaboration for the potential treatment of rheumatoid arthritis (RA).

Global Functional Electrical Stimulation Market Highlights over 2022 – 2031

The global functional electrical stimulation market is estimated to grow at a CAGR of ~8.5% over the forecast period, i.e., 2022 – 2031. Functional electrical stimulation (FES) is an advanced technology of using low-energy electrical pulses to create artificial body movements amongst individuals who are partially or completely paralyzed. The growth of the market can be attributed to the increasing prevalence of musculoskeletal, and central nervous system diseases, which are the main causes of paralysis. As per a report by the World Health Organization (WHO), 0.25 to 0.5 million people suffer from a spinal cord injury, annually. On the other hand, 1.71 billion people suffer from musculoskeletal conditions, out of which, 568 million people have lower back related issues. Moreover, increasing adoption of advanced technology in the healthcare sector, is estimated to boost the market growth.  

Functional Electrical Stimulation Market

The market is segmented by indication into neurological disorders, pain management, musculoskeletal disorders, and others out of which, the neurological disorders segment is anticipated to hold a substantial share in the global functional electrical stimulation market over the forecast period on account of growing incidences of failure of central nervous system, mostly due to accidents or trauma on the spinal cord. Meanwhile, certain diseases, such as, cancer can also spread to the spinal cord or brain, which can cause paralyses. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Functional Electrical Stimulation Market Regional Synopsis

On the basis of geographical analysis, the global functional electrical stimulation market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of increasing prevalence of paralyses in the region. According to the data by the National Organization for Rare Diseases, muscular dystrophy affects around 250,000 individuals in the United States, every year. Moreover, the increasing adoption of advanced technology in the medical industry is estimated to boost the market growth.

The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing healthcare awareness amongst people, along with the improving healthcare infrastructure in the region.

Functional Electrical Stimulation Market Share

The global functional electrical stimulation market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global functional electrical stimulation market includes the following segments:

By Product Type

  • Wired Devices
  • Wireless Devices 
  • Others

By Indication

  • Neurological Disorders
  • Pain Management
  • Musculoskeletal Disorders
  • Others

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Health Center
  • Others

Growth Drivers

  • Increasing Prevalence of Paralysis
  • Growing Adoption of Advanced Technology in Healthcare Sector

Challenges

  • High Operational Cost of Functional Electrical Stimulation

Top Featured Companies Dominating the Market

  • Abbott Laboratories
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.,
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved